Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine versus remifentanil for stress response in mechanically ventilated ICU patients
ISRCTN65709956Phase 4Recruiting
- Sponsor
- Wu Jieping Medical Foundation
- Start
- Feb 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in pain comparing Oliceridine arm with Remifentanil arm (2 arms). Primary endpoint: Total cortisol level. Started Feb 2026; status: recruiting.
02
Drugs
oliceridineremifentanil
03
Conditions
pain
Beyond the preview
Go deeper on ISRCTN65709956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN65709956.